China’s Ministry of Science and Technology (MOST) released a series of frequently asked questions (FAQs) regarding the administration of human genetic resources (HGRs). 

These inquiries were received by MOST after the Implementation Rules on the Administrative Regulations on HGRs took effect in July 2023, as the ministry is responsible for approving HGR usage applications.

BaiPharm has provided a translated version of the FAQs for the convenience of foreign stakeholders. However, in the event of any inconsistency between the translation and the original Chinese version, it is essential to adhere to the official notice issued by MOST. 

The FAQs are divided into four categories: 

1. Administrative licenses for HGR collection and preservation;

2. Administrative License and Filing for International Cooperation;

3. Prior Report Before the Provision or Open Use of Information to External Parties;

4. Other FAQs

Related:

• Biosecurity Law of the People's Republic of China

• Administrative Regulations on Human Genetic Resources of the People's Republic of China

• Implementation Rules on the Administrative Regulations on Human Genetic Resources